OTU domain-containing protein 1 (OTUD1) mRNA (OTUD1 mRNA)

OTUD1 mRNA is the messenger RNA transcript that encodes the OTU domain-containing protein 1, a member of the ovarian tumor (OTU) family of deubiquitinating enzymes (DUBs) (UniProt Q5VV17). The encoded protein plays a pivotal role in regulating cellular signaling by removing ubiquitin chains from key substrates, such as Smad7 in the TGF-beta pathway and YAP in the Hippo pathway, thereby influencing cell growth and apoptosis (PubMed: 29335231, 30249619). In the context of oncology, OTUD1 often functions as a tumor suppressor, and its downregulation is linked to the progression of colorectal and breast cancers, making the stabilization or restoration of its mRNA a potential therapeutic strategy. Conversely, OTUD1 has been shown to regulate the innate immune response by deubiquitinating IRF3, suggesting that modulating its mRNA levels could impact antiviral immunity or autoimmune conditions (PubMed: 30032985). While no small-molecule drugs currently target OTUD1, its mRNA sequence is a viable target for RNA-based therapeutics, including siRNAs and antisense oligonucleotides (ASOs), which are being explored in preclinical research to modulate DUB activity with high specificity. Biotech analysts should note that while targeting the mRNA offers precision, challenges remain regarding the delivery of these nucleic acid drugs to the relevant tissues and the potential for context-dependent biological effects.

Other names

OTUD1 transcriptFAM115A mRNADUBA7 mRNAOTU domain-containing protein 1

Targeting via RNA interference (RNAi) or antisense oligonucleotides (ASOs) to induce mRNA degradation or inhibit translation, thereby modulating the levels of the OTUD1 deubiquitinase protein.